SCHEMBL6559205

SCHEMBL6559205

CCN(C1CC(C)(C)Oc2ccc(C(=O)OC)cc21)S(=O)(=O)CC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.38
TSHR P16473 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
RAB9A P51151 3/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 5/20 0.36
LMNA P02545 2/20 0.36
CNR2 P34972 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 3/20 0.36
HPGD P15428 2/20 0.36
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
KCNE1 P15382 3/20 0.35
KCNQ1 P51787 3/20 0.35
KCNA5 P22460 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559952 0.92 KCNA5 (0.41) SMN1; SMN2TSHRCYP1A2CYP2C19MEN1
SCHEMBL6558710 0.91 KCNA5 (0.35) SMN1; SMN2TSHRCYP1A2CYP2C19MEN1
SCHEMBL6560813 0.89 KCNE1 (0.42) SMN1; SMN2TSHRCYP1A2CYP2C19MEN1
SCHEMBL6559500 0.88 NPSR1 (0.38) SMN1; SMN2CYP1A2CYP2C19MEN1KMT2A
SCHEMBL6559403 0.88 KCNA5 (0.37) SMN1; SMN2TSHRMEN1KMT2ARAB9A
SCHEMBL7830067 0.87 KCNE1 (0.37) SMN1; SMN2TSHRMEN1KMT2ARAB9A
SCHEMBL6559604 0.87 MEN1 (0.36) SMN1; SMN2TSHRCYP1A2CYP2C19MEN1
SCHEMBL6559333 0.85 KCNE1 (0.44) CYP1A2CYP2C19MEN1KMT2ACNR2
SCHEMBL6559277 0.83 KCNE1 (0.40) SMN1; SMN2TSHRMEN1KMT2ARAB9A
SCHEMBL6559569 0.82 RAB9A (0.37) SMN1; SMN2TSHRMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed